Literature DB >> 19371500

Overview of generalized anxiety disorder: epidemiology, presentation, and course.

Risa B Weisberg1.   

Abstract

Generalized anxiety disorder (GAD) was defined relatively recently, and the diagnostic criteria are still being refined. The essential feature of the disorder has changed from persistent anxiety to excessive worry, and the required symptom duration has changed from 1 month to 6 months. Additionally, exclusion criteria involving permissibility of the diagnosis in children and wording regarding the relationship of GAD with mood disorders have changed. Nosologic controversies still surround the criteria for excessive worry, symptom duration, the relationship between GAD and major depressive disorder, and the required number of associated symptoms. Alterations in the criteria have been suggested, but more research is needed on the validity of these proposed changes. Generalized anxiety disorder appears to be highly prevalent. In the United States, the lifetime prevalence of DSM-IV GAD is estimated to be about 5% and the current prevalence to be about 2% to 3%. The disorder is differentially prevalent across gender and ethnic and social groups. The course of GAD is chronic and can be exacerbated by poor family relationships, comorbid cluster C personality disorders, and comorbid Axis I disorders. Impairment and suicidal ideation are associated with GAD. Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19371500

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  28 in total

1.  Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project.

Authors:  Risa B Weisberg; Courtney Beard; Maria E Pagano; Kristin M Maki; Larry Culpepper; Martin B Keller
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear.

Authors:  Hans-Christian Pape; Denis Pare
Journal:  Physiol Rev       Date:  2010-04       Impact factor: 37.312

3.  The impact of stressful life events on relapse of generalized anxiety disorder.

Authors:  Jennifer L Francis; Ethan Moitra; Ingrid Dyck; Martin B Keller
Journal:  Depress Anxiety       Date:  2012-03-16       Impact factor: 6.505

4.  In search of optimal fear inducing stimuli: Differential behavioral responses to computer animated images in zebrafish.

Authors:  Ruxandra M Luca; Robert Gerlai
Journal:  Behav Brain Res       Date:  2011-09-08       Impact factor: 3.332

5.  The association of personality disorders with the prospective 7-year course of anxiety disorders.

Authors:  E B Ansell; A Pinto; M O Edelen; J C Markowitz; C A Sanislow; S Yen; M Zanarini; A E Skodol; M T Shea; L C Morey; J G Gunderson; T H McGlashan; C M Grilo
Journal:  Psychol Med       Date:  2010-09-14       Impact factor: 7.723

6.  Changes in Decentering and Reappraisal Temporally Precede Symptom Reduction During Emotion Regulation Therapy for Generalized Anxiety Disorder With and Without Co-Occurring Depression.

Authors:  Mia S O'Toole; Megan E Renna; Douglas S Mennin; David M Fresco
Journal:  Behav Ther       Date:  2019-01-04

7.  Anxiety among informal hospice caregivers: an exploratory study.

Authors:  Karla T Washington; George Demiris; Kenneth C Pike; Robin L Kruse; Debra Parker Oliver
Journal:  Palliat Support Care       Date:  2014-02-13

Review 8.  Zebrafish antipredatory responses: a future for translational research?

Authors:  Robert Gerlai
Journal:  Behav Brain Res       Date:  2009-10-15       Impact factor: 3.332

Review 9.  The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.

Authors:  Baptiste Pignon; Chloé Tezenas du Montcel; Louise Carton; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2017-11-07       Impact factor: 5.285

10.  Social Epidemiology of Depression and Anxiety by Gender Identity.

Authors:  Sari L Reisner; Sabra L Katz-Wise; Allegra R Gordon; Heather L Corliss; S Bryn Austin
Journal:  J Adolesc Health       Date:  2016-06-04       Impact factor: 5.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.